Imidazopyridazine Compounds for Treating Viral Infections
申请人:Leivers Martin
公开号:US20110052534A1
公开(公告)日:2011-03-03
Disclosed are compounds and compositions of Formula (I), pharmaceutically acceptable salts and solvates thereof, and their preparation and uses for treating viral infections mediated at least in part by a virus in the Flaviviridae family of viruses:
Imidazo[4,5-d]Pyridazine Compounds For Treating Viral Infections
申请人:Leivers Martin
公开号:US20110053892A1
公开(公告)日:2011-03-03
Disclosed are compounds and compositions of Formula (I), pharmaceutically acceptable salts and solvates thereof, and their preparation and uses for treating viral infections mediated at least in part by a virus in the Flaviviridae family of viruses:
[EN] BICYCLIC COMPOUNDS WITH KINASE INHIBITORY ACTIVITY<br/>[FR] COMPOSES BICYCLIQUES AYANT UNE ACTIVITE INHIBITRICE DE KINASE
申请人:MILLENNIUM PHARM INC
公开号:WO2007067444A1
公开(公告)日:2007-06-14
[EN] The present invention provides novel bicyclic compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases. [FR] La présente invention concerne de nouveaux composés bicycliques utiles en tant qu'inhibiteurs de protéine kinases. L'invention concerne en outre des compositions pharmaceutiques comprenant les composés de l'invention et des procédés d'utilisation des compositions dans le traitement de différentes maladies.
[EN] PHENETHYLAMIDE DERIVATIVES WITH KINASE INHIBITORY ACTIVITY<br/>[FR] DÉRIVÉS DE PHÉNÉTHYLAMIDE AVEC UNE ACTIVITÉ INHIBITRICE DE KINASE
申请人:MILLENNIUM PHARM INC
公开号:WO2008030448A1
公开(公告)日:2008-03-13
[EN] The present invention provides novel phenethylamide compounds of formula (I) useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases. [FR] La présente invention concerne de nouveaux composés de phénéthylamide représentés par la formule (I) et convenant comme inhibiteurs de protéines kinases. L'invention concerne également des compositions pharmaceutiques comprenant les composés de l'invention et des procédés d'utilisation des compositions dans le traitement de diverses maladies.